Save your place

Sign in to WhoBought

Please try again later.

Ken Griffin's Recursion Pharmaceuticals, Inc. (RXRX) position

Yes: as of Q1 2026, Ken Griffin holds 625K shares of RXRX worth $1.9M (0.0% of the disclosed portfolio). Last quarter the position was reduced by 85.2%. First disclosed Q4 2021.
View full portfolio →
Current value
$1.9M
Shares held
625K
% of portfolio
0.0%
Est. average buy price (i)
$5.59
est. since Q3 2023
Quarter-end price
$3.07

Estimated trade prices

Average price in quarters with purchases
$7.21
Average prices in quarters with sales
  • Q1 2026: $3.86 (3.6M shares sold)
  • Q2 2025: $4.91 (1.3M shares sold)
  • Q1 2025: $7.29 (84K shares sold)
  • Q3 2024: $7.17 (511K shares sold)
  • Q4 2023: $7.13 (267K shares sold)
  • Q1 2023: $7.93 (166K shares sold)
  • Q2 2022: $6.69 (603K shares sold)

RXRX price vs Griffin's position

Dates
$2$4$6$82026Added 34K shares (2.6%) · Q3 2025. Average closing price $5.25 · Price range $4.52–$6.5434KsharespurchasedAdded 2.9M shares (213.6%) · Q4 2025. Average closing price $4.95 · Price range $3.85–$6.792.9MsharespurchasedSold 3.6M shares (85.2%) · Q1 2026. Average closing price $3.86 · Price range $2.84–$4.963.6Msharessold← Earlier —8 purchases, 6 sells
Average closing price · filing quarter
$3.86
Price range · filing quarter
$2.84 – $4.96

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Reduced −3.6M −$14M −85.2% 625K May 15, 2026
Q4 2025 Added +2.9M +$14M +213.6% 4.2M Feb 17, 2026
Q3 2025 Added +34K +$179K +2.6% 1.3M Nov 14, 2025
Q2 2025 Reduced −1.3M −$6.6M −50.5% 1.3M Aug 14, 2025
Q1 2025 Reduced −84K −$609K −3.0% 2.7M May 15, 2025
Q4 2024 Added +2.5M +$17M +1,069.5% 2.7M Feb 14, 2025
Q3 2024 Reduced −511K −$3.7M −68.6% 234K Nov 14, 2024
Q2 2024 Added +405K +$3.5M +118.9% 745K Aug 14, 2024
Q1 2024 Added +304K +$3.4M +832.7% 340K May 15, 2024
Q4 2023 Reduced −267K −$1.9M −88.0% 36K Feb 14, 2024
Q3 2023 First covered 303K Nov 14, 2023
Q2 2023 Added +132K +$925K +21.8% 738K Aug 14, 2023
Q1 2023 Reduced −166K −$1.3M −21.5% 606K May 15, 2023
Q4 2022 Added +269K +$2.6M +53.7% 771K Feb 14, 2023
Q3 2022 Added +194K +$2.0M +63.3% 502K Nov 14, 2022
Q2 2022 Reduced −603K −$4.0M −66.2% 307K Aug 15, 2022
Q1 2022 Added +710K +$7.5M +355.9% 910K May 16, 2022
Q4 2021 New +200K +$3.8M 200K Feb 14, 2022
Data through Q1 2026 · filed May 15, 2026
18 grouped rows from 18 quarters

More Griffin positions

Common questions

Does Ken Griffin own RXRX?

Yes. As of Q1 2026, Ken Griffin disclosed 625K shares of RXRX, worth $1.9M. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Ken Griffin buy RXRX?

Ken Griffin first disclosed a RXRX position in Q4 2021; every quarterly buy and sell since is in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Ken Griffin sell RXRX?

The quarter-by-quarter table above shows each sale and reduction Ken Griffin disclosed in RXRX. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of RXRX does Ken Griffin own?

Ken Griffin disclosed 625K shares of RXRX as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Ken Griffin pay for RXRX?

Ken Griffin began building the RXRX position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.